SPG7 and amyotrophic lateral sclerosis: Taken together, in 9 of 214 (4.2%) ALS patients we identified five different rare SPG7 variants predicted to be deleterious, four missense and one essential splice site variant, all of which were heterozygous (Fig. 1a, d).